Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Michigan Entrepreneur, Cancer Survivor Pledges $1 Million Legacy Gift to support research at AHN Cancer Institute


News provided by

Allegheny Health Network

Jul 27, 2023, 13:03 ET

Share this article

Share toX

Share this article

Share toX

Granata family’s philanthropic gift, which establishes a new endowed fund at AHN, will support the network’s Peritoneal Surgery Program
Granata family’s philanthropic gift, which establishes a new endowed fund at AHN, will support the network’s Peritoneal Surgery Program

Granata family's philanthropic gift, which establishes a new endowed fund at AHN, will support the network's Peritoneal Surgery Program

PITTSBURGH, July 27, 2023 /PRNewswire-PRWeb/ -- The family of Robert J. Granata, a cancer survivor and Michigan entrepreneur, has donated $1 million to support research carried out at Allegheny Health Network Cancer Institute's (AHNCI) Peritoneal Surgery Program.

The Granata family's planned gift serves as a gesture of his gratitude for the innovative and life-saving work offered by clinicians at AHNCI, specifically David Bartlett, MD, chair of the AHNCI and an internationally recognized cancer specialist with expertise in peritoneal surgery.

I’m grateful I was able to locate Dr. Bartlett and will forever be indebted to his life-saving work. My intention with this pledge is to create future opportunities for others in similar situations to ensure they can continue living far beyond their diagnosis.

Post this

In 2014, Mr. Granata was told he only had three months to live following the diagnosis of a rare and aggressive stage 4 appendiceal cancer. Doctors had discovered that his appendiceal cancer had advanced throughout his abdominal tissues, colon, and abdominal lymph nodes.

Mr. Granata sought out Dr. Bartlett, a pioneer in hyperthermic intraperitoneal chemotherapy (HIPEC), who performed two life-saving surgeries on him.

The HIPEC procedure is preceded by a major debulking surgery to remove all visible tumors and cancer within the abdomen. Next, the abdominal cavity is bathed with a heated chemotherapy solution to kill off remaining microscopic cancer cells – the chemotherapy solution is heated to between 107 and 109 degrees, which is hot enough to destroy cancer cells, but not healthy tissue.

In all, the HIPEC surgery can last 8-12 hours. Few surgeons in the world have Dr. Bartlett's level of experience and expertise with the procedure, which is why patients from around the country and world come to AHN. Mr. Granata lives in Birmingham, Michigan, a suburb of Detroit.

"Compared to standard chemo, surgery plus HIPEC significantly improves survival from many cancers," said Dr. Bartlett. "About 10 to 15 percent of patients are cancer-free long-term."

Since undergoing treatment at AHN in 2019, Mr. Granata has had no evidence of cancer in his body and in gratitude he has spearheaded several philanthropic efforts to support the growth of the AHN Peritoneal Surgery Program and to advance Dr. Bartlett's research aimed at the development of new therapies and helping patients avoid invasive surgical treatment.

In addition to his previous gifts to the Bartlett Cancer Research Fund, the Granata family has pledged to posthumously donate a $1 million legacy gift to sustain and advance the Peritoneal Surgery Program for AHNCI, and create hope for patients in the future.

"Upon receiving my diagnosis in 2014, I was determined to do whatever I needed to in order to continue living," shared Mr. Granata. "I'm grateful I was able to locate Dr. Bartlett and will forever be indebted to his life-saving work. My intention with this pledge is to create future opportunities for others in similar situations to ensure they can continue living far beyond their diagnosis."

The new $1 million gift will formally establish the Granata Family Endowed Fund in Innovative Cancer Research at AHN. The Granata family's hope with this new fund is that it will become a catalyst for additional major philanthropic funding to support this critical area of research.

In addition to his philanthropic gifts to AHN, Mr. Granata has launched an international Patient Ambassador Team comprised of patients treated by Dr. Bartlett and Dr. Patrick Wagner, an AHN surgical oncologist who specializes in abdominal tumors.
Cancer patients from across the world have traveled to AHNCI facilities in Pittsburgh and Erie to receive innovative and life-saving care from AHN's skilled oncologists. Under Mr. Granata's direction, many of these patients have come together to help shape and expand a Global Referral Program and make AHNCI an international destination center for the treatment of complex cancers and ensure that patients who need this specialty treatment are aware of where they can find it.

"Our goal is to offer patients the latest therapeutic innovations and advanced treatment regimens to fight even the most aggressive cancers, and Mr. Granata's outcome has been exceptional," said Dr. Bartlett. "His incredible generosity and ongoing work with our team will create a remarkable legacy that spurs the development of additional cancer treatment breakthroughs in the future, enabling us to bring even greater hope to others facing similar rare cancer diagnoses."

Mr. Granata also initiated a pilot project to redesign patient gowns to create more privacy, comfort, and functionality for patients in both the outpatient and inpatient settings, inspired by his experience with months-long stays in the hospital following his HIPEC procedures. In conjunction with AHNCI, Mr. Granata has led several focus groups and surveys with stakeholders, including patients and caregivers, to gather input to create a more functional "dignity gown" that allows for more privacy for the patient.

To learn more about the AHN Cancer Institute, visit https://www.ahn.org/services/cancer.

About the Allegheny Health Network – and the AHN Cancer Institute
Allegheny Health Network is a western Pennsylvania-based integrated healthcare system that serves patients from across a five-state region that includes western Pennsylvania and the adjacent regions of Ohio, West Virginia, Maryland, and New York. The Network's Cancer Institute employs more than 200 physicians and 500 oncology professionals who provide a complete spectrum of oncology care at 24 affiliated oncology clinics, including access to state-of-the-art technologies and new therapies being explored in hundreds of clinical cancer trials. The Cancer Institute has the only cancer program in the Pittsburgh region accredited as an Integrated Network Cancer Program by the American College of Surgeons Commission on Cancer, and its radiation oncology program is the largest in the country accredited by the American Society for Radiation Oncology. AHN Cancer Institute is a Quality Oncology Practice Initiative certified practice, and is accredited by the Foundation for Accreditation of Cellular Therapy, National Accreditation Program for Breast Centers and the National Accreditation Program for Rectal Cancer.

Media Contact

Emily Beatty, Allegheny Health Network, 5136789620, [email protected]

SOURCE Allegheny Health Network

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.